HOME >> BIOLOGY >> NEWS
Stockpile bird flu vaccine now

GOVERNMENTS should consider stockpiling vaccine against H5N1 bird flu now, before a pandemic starts, a World Health Organization report out next month will advise. The change in policy reflects growing fears that an H5 pandemic is likely, and that there will not be time to produce much vaccine once it starts. "When we realised H5N1 is not going to be eradicated in poultry in Asia for at least another couple of years, that made the risk of H5 much higher," Klaus Sthr, head of the WHO's influenza team, told New Scientist.

The US has already contracted manufacturers to make 4 million doses, while at a meeting at WHO headquarters in Geneva last week Italy and France said they plan to stockpile 2 million doses each. But in a world of over 6 billion people that is nowhere near enough to make a significant difference, as Sthr points out. "This is an option only for affluent countries, and then for a fraction of their population," he says. "It won't change a lot at the global level."

Until now the WHO has said that a vaccine cannot be made until a pandemic starts, as only then can it be based on the exact strain of the virus responsible. "Normally there is no point stockpiling vaccine, because you don't know which flu will cause the next pandemic," Sthr says. "It could be H7 or H9." But the failure to halt the H5N1 bird flu outbreaks in Asia, and the growing number of human cases (see Table), is changing minds. Recent findings also suggest that a stockpiled vaccine could provide some protection even if it does not exactly match the pandemic virus.

Experiments on animals at St Jude's Children's Hospital in Memphis, Tennessee, show that while previous exposure to similar strains may not stop them falling ill when infected with H5N1 flu, it can prevent them dying. What's more, people normally require two shots of a vaccine to make them immune to a strain of flu they have not encountered before. An H5 vaccine would prime people's immune systems, so they would need onl
'"/>


16-Feb-2005


Page: 1 2 3

Related biology news :

1. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
2. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
3. Handicapping tuberculosis may be the way to a better vaccine
4. Developing a more effective vaccine for tuberculosis
5. New target for HIV/AIDS drugs and vaccine discovered
6. Genomic analysis uncovers new targets for HIV vaccine
7. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
8. Universal flu vaccine being tested on humans
9. From clinical cancer research: rethinking therapeutic cancer vaccine trials
10. Paving the way toward a vaccine against Alzheimers disease
11. Mucosal-surface immune function discoveries could boost vaccine research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2019)... ... December 17, 2019 , ... ... for a Digital World at The Fletcher School, Tufts University, is pleased to ... the digital learning experience of students using Macmillan Learning’s acclaimed series of economics ...
(Date:12/14/2019)... ... December 12, 2019 , ... Crop Enhancement ... has appointed Jean Pougnier as chief business officer. Mr. Pougnier will lead the ... influencers that will position the company for maximum commercial success. As part of ...
(Date:12/2/2019)... (PRWEB) , ... December 01, 2019 , ... ... latest and greatest tools, technologies, and techniques to hit the life-science landscape. For ... of innovative products speeding work in laboratories and facilitating biological discovery. This year’s ...
Breaking Biology News(10 mins):
(Date:12/27/2019)... ... December 27, 2019 , ... ... for its 505(b)(2) product pipeline that offers patients and healthcare providers ... products concepts were identified in collaboration with doctors and managed care professionals and ...
(Date:12/18/2019)... SCOTTSDALE, Ariz. (PRWEB) , ... December 17, 2019 ... ... it has received its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since ... where closest competitors, Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) ...
(Date:12/18/2019)... (PRWEB) , ... December 18, 2019 , ... Tune in ... Advancements, hosted by Ted Danson. Check local listings for more information on this program. ... in augmented reality are helping to simplify complex system to increase the efficiency, safety ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... clearance for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein ... great benefits for first-in-line treatment for nonsurgical removal of soft emboli and ...
Breaking Biology Technology:
Cached News: